Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

Principal Investigators (PI) may request approval of a waiver or reduction of the indirect (F&A) rate when the potential benefits are compelling and well-justified. Waivers are only considered under ...